Therefore, an application for an antimicrobial veterinary medicinal product should contain information about the potential risks that use of that medicinal product may lead to the development of antimicrobial resistance in humans or animals or in organisms associated with them.
Dá bhrí sin, ba cheart faisnéis a bheith mar chuid d’iarratas ar tháirge íocshláinte tréidliachta faoi na rioscaí féideartha go bhféadfadh frithsheasmhacht in aghaidh ábhair fhrithmhiocróbacha teacht chun cinn i ndaoine nó in ainmhithe, nó in orgánaigh a bhaineann leo, mar thoradh ar úsáid an táirge íocshláinte sin.